T-Spot TB Test

The T-Spot TB is a type of Elispot blood test approved by the United States Food and Drug Administration (FDA).

A blood sample is collected from a patient with a suspected TB infection. The blood is centrifuged to separate out the peripheral blood mononuclear cells (PBMCs) which include lymphocytic T-cells. These PBMCs are washed and together with TB specific antigens, they are placed in wells pre-coated with antibodies to IFN-gamma and incubated overnight at 37 degrees C. IFN-gamma is released from the lymphocytic T-cells.

A second antibody is added which binds to the interferon antibody, now serving as an antigen A solution is then added which produces dark blue spots in the action wells where the interferon–gamma was secreted by the T–cells. These dark blue spots are counted, and depending on how many of them are present, the sample is either reported as positive, borderline/equivalent, or negative for exposure to or infection with bacteria that cause TB.

(T-SPOT. TB –P070006, United States Food and Drug Administration [FDA], CDRH Consumer Information, 2008).




Return to What Is Tuberculosis?

Return from T-Spot TB Test to Medical Exam Essentials homepage

Don’t Miss
A Primer in Adult
Physical Diagnosis

With a 30-Day Money Back Guarantee, there is no risk involved in trying this handy new eBook.

Download the PDF now and start mastering the skills necessary for Physical Diagnosis.


Sign up for Periodic Site Updates

Add your name and e-mail address, and we’ll send you periodic site updates when we add other valuable documents for Medical Students.